LUNGLIFE AI, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19 GBX | 0.00% |
|
-7.32% | -58.70% |
| 05/04 | Transcript : LungLife AI, Inc., 2023 Earnings Call, Apr 05, 2024 | |
| 04/04 | LungLife reports narrowed losses in year of "considerable achievement" | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Bio Diagnostics & Testing
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 74.41L | - | - | - | - | ||
| 919.7Cr | - | |||||
| 312.29Cr | - | |||||
| 280.11Cr | - | |||||
| 206.79Cr | - | - | - | - | - | |
| 159.01Cr | - |
- Stock Market
- Equities
- LLAI Stock
- Charts LungLife AI, Inc.
- Sector Chart
